{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.12.1346","meta":{"versionId":"2","lastUpdated":"2017-05-04T01:00:13.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1346","version":"20170504","name":"Naloxone / Pentazocine","status":"active","date":"2017-05-04T01:00:13-04:00","publisher":"NCQA PHEMUR","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1347"]}]},"expansion":{"identifier":"urn:uuid:c0816ea0-b094-4602-a6e9-31bd9745539d","timestamp":"2022-06-10T09:58:55-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"312289","display":"naloxone 0.5 MG / pentazocine 50 MG Oral Tablet"}]}}